Primary |
Local Anaesthesia |
30.6% |
Anaesthesia |
8.2% |
Product Used For Unknown Indication |
8.2% |
Hypertension |
6.1% |
Arrhythmia Prophylaxis |
4.1% |
Colectomy |
4.1% |
Enthesopathy |
4.1% |
Nerve Block |
4.1% |
Prophylaxis |
4.1% |
Sedation |
4.1% |
Skin Laceration |
4.1% |
Analgesic Therapy |
2.0% |
Anxiety |
2.0% |
Atrial Fibrillation |
2.0% |
Bronchitis |
2.0% |
Bronchoscopy |
2.0% |
Cataract Operation |
2.0% |
Depression |
2.0% |
Epilepsy |
2.0% |
Joint Sprain |
2.0% |
|
Intentional Overdose |
12.9% |
Anaphylactic Reaction |
6.5% |
Myocardial Infarction |
6.5% |
Rash Erythematous |
6.5% |
Sensory Loss |
6.5% |
Tachycardia |
6.5% |
Toxicity To Various Agents |
6.5% |
Vision Blurred |
6.5% |
Visual Acuity Reduced |
6.5% |
Cardio-respiratory Arrest |
3.2% |
Circulatory Collapse |
3.2% |
Drug Administration Error |
3.2% |
Epilepsy |
3.2% |
Expired Drug Administered |
3.2% |
Eyelid Oedema |
3.2% |
Feeling Cold |
3.2% |
Incorrect Route Of Drug Administration |
3.2% |
Injection Site Reaction |
3.2% |
Loss Of Consciousness |
3.2% |
Optic Neuropathy |
3.2% |
|
Secondary |
Drug Use For Unknown Indication |
21.2% |
Local Anaesthesia |
14.4% |
Product Used For Unknown Indication |
9.6% |
Antibiotic Therapy |
5.8% |
Arthrogram |
5.8% |
Anaesthesia |
3.8% |
Analgesia |
3.8% |
Hypertension |
3.8% |
Induction Of Anaesthesia |
3.8% |
Sedation |
3.8% |
Skin Laceration |
3.8% |
Intervertebral Disc Protrusion |
2.9% |
Premedication |
2.9% |
Tooth Disorder |
2.9% |
Acinetobacter Infection |
1.9% |
Arrhythmia |
1.9% |
Arthralgia |
1.9% |
Arthropathy |
1.9% |
Back Pain |
1.9% |
Blood Calcium Decreased |
1.9% |
|
Visual Acuity Reduced |
15.4% |
Sensory Loss |
10.3% |
Tachycardia |
10.3% |
Oropharyngeal Blistering |
7.7% |
Arthralgia |
5.1% |
Cardiac Failure |
5.1% |
Inflammation |
5.1% |
Loss Of Consciousness |
5.1% |
Swollen Tongue |
5.1% |
Ventricular Fibrillation |
5.1% |
Anaphylactic Reaction |
2.6% |
Circulatory Collapse |
2.6% |
Erythema Multiforme |
2.6% |
Feeling Cold |
2.6% |
Intraocular Pressure Test |
2.6% |
No Adverse Event |
2.6% |
Palpitations |
2.6% |
Premature Baby |
2.6% |
Pulmonary Oedema |
2.6% |
Rash Erythematous |
2.6% |
|
Concomitant |
Product Used For Unknown Indication |
16.9% |
Drug Use For Unknown Indication |
15.4% |
Cataract Operation |
10.0% |
Angina Pectoris |
7.3% |
Acute Myocardial Infarction |
6.0% |
Anaesthesia |
6.0% |
Hiv Infection |
4.8% |
Local Anaesthesia |
4.8% |
Prophylaxis |
3.9% |
Drug Hypersensitivity |
3.6% |
Complex Regional Pain Syndrome |
2.7% |
Cycloplegia |
2.4% |
Pain |
2.4% |
Prophylaxis Of Nausea And Vomiting |
2.4% |
General Anaesthesia |
2.1% |
Spinal Anaesthesia |
2.1% |
Mucosal Inflammation |
1.8% |
Postoperative Care |
1.8% |
Squamous Cell Carcinoma |
1.8% |
Medication Dilution |
1.5% |
|
Oedema |
12.2% |
Anaemia |
8.2% |
Visual Acuity Reduced |
8.2% |
Renal Failure Acute |
6.1% |
Retinal Injury |
6.1% |
Toxicity To Various Agents |
6.1% |
Upper Gastrointestinal Haemorrhage |
6.1% |
Wrong Technique In Drug Usage Process |
6.1% |
Cardiac Arrest |
4.1% |
Postpartum Haemorrhage |
4.1% |
Sleep Disorder |
4.1% |
Syncope |
4.1% |
Synovitis |
4.1% |
Thrombocytopenia |
4.1% |
Vision Blurred |
4.1% |
Vomiting |
4.1% |
Anaphylactic Reaction |
2.0% |
Cerebrovascular Accident |
2.0% |
Circulatory Collapse |
2.0% |
Hypotension |
2.0% |
|
Interacting |
Atrial Fibrillation |
100.0% |
|
|